CD19 target-engineered T-cells accumulate at tumor lesions in human B-cell lymphoma xenograft mouse models.

about

The Tol2 transposon system mediates the genetic engineering of T-cells with CD19-specific chimeric antigen receptors for B-cell malignancies.Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells.

P2860

Q38937542-65E3BD5A-7A9F-4C40-9FA7-CC98BC83E00F Q40965523-0C5DE5E6-6ACF-443F-9553-455BC16CEF90

P2860

CD19 target-engineered T-cells accumulate at tumor lesions in human B-cell lymphoma xenograft mouse models.

Item

http://www.wikidata.org/entity/Q39122928

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

CD19 target-engineered T-cells ...... mphoma xenograft mouse models.

@en

CD19 target-engineered T-cells ...... mphoma xenograft mouse models.

@nl

type

Item

label

CD19 target-engineered T-cells ...... mphoma xenograft mouse models.

@en

CD19 target-engineered T-cells ...... mphoma xenograft mouse models.

@nl

prefLabel

CD19 target-engineered T-cells ...... mphoma xenograft mouse models.

@en

CD19 target-engineered T-cells ...... mphoma xenograft mouse models.

@nl

P1476

CD19 target-engineered T-cells ...... mphoma xenograft mouse models.

@en

P2093

Akihiro Kume

http://www.w3.org/2001/XMLSchema#string

Chihiro Yamamoto

http://www.w3.org/2001/XMLSchema#string

Hiroaki Mizukami

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Ido

http://www.w3.org/2001/XMLSchema#string

Isabelle Riviere

http://www.w3.org/2001/XMLSchema#string

Junichi Mineno

http://www.w3.org/2001/XMLSchema#string

Kazutoh Takesako

http://www.w3.org/2001/XMLSchema#string

Keiya Ozawa

http://www.w3.org/2001/XMLSchema#string

Ken Ohmine

http://www.w3.org/2001/XMLSchema#string

Masashi Urabe

http://www.w3.org/2001/XMLSchema#string

P2860

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

Interleukin 12-dependent interferon gamma production by CD8alpha+ lymphoid dendritic cells

Modulation of hematopoiesis in mice with a truncated mutant of the interleukin-2 receptor gamma chain

RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement

CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

4-1BB and CD28 signaling plays a synergistic role in redirecting umbilical cord blood T cells against B-cell malignancies

Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells.

P304

84-89

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBRC.2013.07.030

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

438

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23872144

http://www.w3.org/2001/XMLSchema#string

P921

xenograft

P932

5554955

http://www.w3.org/2001/XMLSchema#string

CD19 target-engineered T-cells accumulate at tumor lesions in human B-cell lymphoma xenograft mouse models.

about

P2860

P2860

CD19 target-engineered T-cells accumulate at tumor lesions in human B-cell lymphoma xenograft mouse models.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932